Consumer Fear Cancels European GM Research

Erica P. Johnson A new Eurobarometer, surveying attitudes about science among citizens of the ten countries that recently entered the European Union, suggests that genetically modified (GM) organisms are only slightly more tolerable to these "new Europeans" than to their peers on the rest of the continent. Seventy-nine percent of the 12,247 people surveyed in 13 countries by the Gallup Organization in Hungary say GM foods should be introduced only if proven safe, compared with 86% of the 16,02

Written byAlexander Hellemans
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

A new Eurobarometer, surveying attitudes about science among citizens of the ten countries that recently entered the European Union, suggests that genetically modified (GM) organisms are only slightly more tolerable to these "new Europeans" than to their peers on the rest of the continent. Seventy-nine percent of the 12,247 people surveyed in 13 countries by the Gallup Organization in Hungary say GM foods should be introduced only if proven safe, compared with 86% of the 16,029 surveyed in 15 member states in December 2001.1, 2

Opposition to GM crops reached a peak during the mid-1990s in response to public pressure, and in 1998, the European Union introduced a de facto moratorium on the import and production of GM foods. In March, the European Commission decided to uphold the de facto moratorium, and it is also standing firm that any food containing more than 0.9% of a GM product would carry ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies